Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment Article Swipe
Stuart Isaacson
,
Robert A. Hauser
,
Rajesh Pahwa
,
David Gray
,
Sridhar Duvvuri
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.prdoa.2023.100212
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.prdoa.2023.100212
Related Topics
Concepts
Dopamine receptor D2
Dopaminergic
Levodopa
Dopamine
Dopamine receptor D3
Dyskinesia
Agonist
Parkinson's disease
Neuroscience
Pharmacology
Dopamine receptor
Medicine
Tolerability
Dopamine receptor D1
Psychology
Adverse effect
Receptor
Internal medicine
Disease
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.prdoa.2023.100212
- OA Status
- gold
- Cited By
- 33
- References
- 102
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4383497684
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4383497684Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.prdoa.2023.100212Digital Object Identifier
- Title
-
Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatmentWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-01-01Full publication date if available
- Authors
-
Stuart Isaacson, Robert A. Hauser, Rajesh Pahwa, David Gray, Sridhar DuvvuriList of authors in order
- Landing page
-
https://doi.org/10.1016/j.prdoa.2023.100212Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.prdoa.2023.100212Direct OA link when available
- Concepts
-
Dopamine receptor D2, Dopaminergic, Levodopa, Dopamine, Dopamine receptor D3, Dyskinesia, Agonist, Parkinson's disease, Neuroscience, Pharmacology, Dopamine receptor, Medicine, Tolerability, Dopamine receptor D1, Psychology, Adverse effect, Receptor, Internal medicine, DiseaseTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
33Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 16, 2024: 15, 2023: 2Per-year citation counts (last 5 years)
- References (count)
-
102Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4383497684 |
|---|---|
| doi | https://doi.org/10.1016/j.prdoa.2023.100212 |
| ids.doi | https://doi.org/10.1016/j.prdoa.2023.100212 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37497384 |
| ids.openalex | https://openalex.org/W4383497684 |
| fwci | 10.13796941 |
| type | review |
| title | Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment |
| biblio.issue | |
| biblio.volume | 9 |
| biblio.last_page | 100212 |
| biblio.first_page | 100212 |
| topics[0].id | https://openalex.org/T10085 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994999766349792 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2728 |
| topics[0].subfield.display_name | Neurology |
| topics[0].display_name | Parkinson's Disease Mechanisms and Treatments |
| topics[1].id | https://openalex.org/T10919 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.996999979019165 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | Neurological disorders and treatments |
| topics[2].id | https://openalex.org/T11123 |
| topics[2].field.id | https://openalex.org/fields/32 |
| topics[2].field.display_name | Psychology |
| topics[2].score | 0.9675999879837036 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3203 |
| topics[2].subfield.display_name | Clinical Psychology |
| topics[2].display_name | Obsessive-Compulsive Spectrum Disorders |
| is_xpac | False |
| apc_list.value | 2400 |
| apc_list.currency | USD |
| apc_list.value_usd | 2400 |
| apc_paid.value | 2400 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2400 |
| concepts[0].id | https://openalex.org/C44208683 |
| concepts[0].level | 3 |
| concepts[0].score | 0.669937789440155 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q15335165 |
| concepts[0].display_name | Dopamine receptor D2 |
| concepts[1].id | https://openalex.org/C137183658 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6658025979995728 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q461076 |
| concepts[1].display_name | Dopaminergic |
| concepts[2].id | https://openalex.org/C2780304432 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6599712371826172 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q300989 |
| concepts[2].display_name | Levodopa |
| concepts[3].id | https://openalex.org/C513476851 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6569933891296387 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q170304 |
| concepts[3].display_name | Dopamine |
| concepts[4].id | https://openalex.org/C199596767 |
| concepts[4].level | 4 |
| concepts[4].score | 0.6568536758422852 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q21110872 |
| concepts[4].display_name | Dopamine receptor D3 |
| concepts[5].id | https://openalex.org/C2780405171 |
| concepts[5].level | 4 |
| concepts[5].score | 0.5941999554634094 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q629444 |
| concepts[5].display_name | Dyskinesia |
| concepts[6].id | https://openalex.org/C2778938600 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5357394218444824 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q389934 |
| concepts[6].display_name | Agonist |
| concepts[7].id | https://openalex.org/C2779734285 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4959903657436371 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11085 |
| concepts[7].display_name | Parkinson's disease |
| concepts[8].id | https://openalex.org/C169760540 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4849731922149658 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q207011 |
| concepts[8].display_name | Neuroscience |
| concepts[9].id | https://openalex.org/C98274493 |
| concepts[9].level | 1 |
| concepts[9].score | 0.48218265175819397 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[9].display_name | Pharmacology |
| concepts[10].id | https://openalex.org/C120069818 |
| concepts[10].level | 3 |
| concepts[10].score | 0.47521668672561646 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q415496 |
| concepts[10].display_name | Dopamine receptor |
| concepts[11].id | https://openalex.org/C71924100 |
| concepts[11].level | 0 |
| concepts[11].score | 0.47430184483528137 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[11].display_name | Medicine |
| concepts[12].id | https://openalex.org/C2778375690 |
| concepts[12].level | 3 |
| concepts[12].score | 0.4530770480632782 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7814214 |
| concepts[12].display_name | Tolerability |
| concepts[13].id | https://openalex.org/C120750228 |
| concepts[13].level | 4 |
| concepts[13].score | 0.41628026962280273 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q2035393 |
| concepts[13].display_name | Dopamine receptor D1 |
| concepts[14].id | https://openalex.org/C15744967 |
| concepts[14].level | 0 |
| concepts[14].score | 0.37253665924072266 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q9418 |
| concepts[14].display_name | Psychology |
| concepts[15].id | https://openalex.org/C197934379 |
| concepts[15].level | 2 |
| concepts[15].score | 0.32836347818374634 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[15].display_name | Adverse effect |
| concepts[16].id | https://openalex.org/C170493617 |
| concepts[16].level | 2 |
| concepts[16].score | 0.30415552854537964 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[16].display_name | Receptor |
| concepts[17].id | https://openalex.org/C126322002 |
| concepts[17].level | 1 |
| concepts[17].score | 0.2832796573638916 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[17].display_name | Internal medicine |
| concepts[18].id | https://openalex.org/C2779134260 |
| concepts[18].level | 2 |
| concepts[18].score | 0.26869943737983704 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[18].display_name | Disease |
| keywords[0].id | https://openalex.org/keywords/dopamine-receptor-d2 |
| keywords[0].score | 0.669937789440155 |
| keywords[0].display_name | Dopamine receptor D2 |
| keywords[1].id | https://openalex.org/keywords/dopaminergic |
| keywords[1].score | 0.6658025979995728 |
| keywords[1].display_name | Dopaminergic |
| keywords[2].id | https://openalex.org/keywords/levodopa |
| keywords[2].score | 0.6599712371826172 |
| keywords[2].display_name | Levodopa |
| keywords[3].id | https://openalex.org/keywords/dopamine |
| keywords[3].score | 0.6569933891296387 |
| keywords[3].display_name | Dopamine |
| keywords[4].id | https://openalex.org/keywords/dopamine-receptor-d3 |
| keywords[4].score | 0.6568536758422852 |
| keywords[4].display_name | Dopamine receptor D3 |
| keywords[5].id | https://openalex.org/keywords/dyskinesia |
| keywords[5].score | 0.5941999554634094 |
| keywords[5].display_name | Dyskinesia |
| keywords[6].id | https://openalex.org/keywords/agonist |
| keywords[6].score | 0.5357394218444824 |
| keywords[6].display_name | Agonist |
| keywords[7].id | https://openalex.org/keywords/parkinsons-disease |
| keywords[7].score | 0.4959903657436371 |
| keywords[7].display_name | Parkinson's disease |
| keywords[8].id | https://openalex.org/keywords/neuroscience |
| keywords[8].score | 0.4849731922149658 |
| keywords[8].display_name | Neuroscience |
| keywords[9].id | https://openalex.org/keywords/pharmacology |
| keywords[9].score | 0.48218265175819397 |
| keywords[9].display_name | Pharmacology |
| keywords[10].id | https://openalex.org/keywords/dopamine-receptor |
| keywords[10].score | 0.47521668672561646 |
| keywords[10].display_name | Dopamine receptor |
| keywords[11].id | https://openalex.org/keywords/medicine |
| keywords[11].score | 0.47430184483528137 |
| keywords[11].display_name | Medicine |
| keywords[12].id | https://openalex.org/keywords/tolerability |
| keywords[12].score | 0.4530770480632782 |
| keywords[12].display_name | Tolerability |
| keywords[13].id | https://openalex.org/keywords/dopamine-receptor-d1 |
| keywords[13].score | 0.41628026962280273 |
| keywords[13].display_name | Dopamine receptor D1 |
| keywords[14].id | https://openalex.org/keywords/psychology |
| keywords[14].score | 0.37253665924072266 |
| keywords[14].display_name | Psychology |
| keywords[15].id | https://openalex.org/keywords/adverse-effect |
| keywords[15].score | 0.32836347818374634 |
| keywords[15].display_name | Adverse effect |
| keywords[16].id | https://openalex.org/keywords/receptor |
| keywords[16].score | 0.30415552854537964 |
| keywords[16].display_name | Receptor |
| keywords[17].id | https://openalex.org/keywords/internal-medicine |
| keywords[17].score | 0.2832796573638916 |
| keywords[17].display_name | Internal medicine |
| keywords[18].id | https://openalex.org/keywords/disease |
| keywords[18].score | 0.26869943737983704 |
| keywords[18].display_name | Disease |
| language | en |
| locations[0].id | doi:10.1016/j.prdoa.2023.100212 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210203201 |
| locations[0].source.issn | 2590-1125 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2590-1125 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Clinical Parkinsonism & Related Disorders |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Clinical Parkinsonism & Related Disorders |
| locations[0].landing_page_url | https://doi.org/10.1016/j.prdoa.2023.100212 |
| locations[1].id | pmid:37497384 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Clinical parkinsonism & related disorders |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37497384 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10366643 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by-nc-nd |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10366643/pdf/main.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Clin Park Relat Disord |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10366643 |
| locations[3].id | pmh:oai:doaj.org/article:6bb39d7d90864ed6bf7da28ea879c603 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Clinical Parkinsonism & Related Disorders, Vol 9, Iss , Pp 100212- (2023) |
| locations[3].landing_page_url | https://doaj.org/article/6bb39d7d90864ed6bf7da28ea879c603 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5060664922 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9914-5706 |
| authorships[0].author.display_name | Stuart Isaacson |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210126793 |
| authorships[0].affiliations[0].raw_affiliation_string | Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL |
| authorships[0].institutions[0].id | https://openalex.org/I4210126793 |
| authorships[0].institutions[0].ror | https://ror.org/02ycs5538 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210126793 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Parkinson's Research and Education Foundation |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Stuart H. Isaacson |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL |
| authorships[1].author.id | https://openalex.org/A5080057970 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6369-1203 |
| authorships[1].author.display_name | Robert A. Hauser |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2613432, https://openalex.org/I2802640032, https://openalex.org/I4210165328 |
| authorships[1].affiliations[0].raw_affiliation_string | Parkinson's Disease and Movement Disorders Center, Parkinson Foundation Center of Excellence, University of South Florida, Tampa, FL |
| authorships[1].institutions[0].id | https://openalex.org/I2802640032 |
| authorships[1].institutions[0].ror | https://ror.org/0377f6951 |
| authorships[1].institutions[0].type | nonprofit |
| authorships[1].institutions[0].lineage | https://openalex.org/I2802640032 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Foundation Center |
| authorships[1].institutions[1].id | https://openalex.org/I4210165328 |
| authorships[1].institutions[1].ror | https://ror.org/05mx85j86 |
| authorships[1].institutions[1].type | nonprofit |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210087553, https://openalex.org/I4210165328 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | Parkinson's Foundation |
| authorships[1].institutions[2].id | https://openalex.org/I2613432 |
| authorships[1].institutions[2].ror | https://ror.org/032db5x82 |
| authorships[1].institutions[2].type | education |
| authorships[1].institutions[2].lineage | https://openalex.org/I2613432 |
| authorships[1].institutions[2].country_code | US |
| authorships[1].institutions[2].display_name | University of South Florida |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Robert A. Hauser |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Parkinson's Disease and Movement Disorders Center, Parkinson Foundation Center of Excellence, University of South Florida, Tampa, FL |
| authorships[2].author.id | https://openalex.org/A5009117789 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3176-6466 |
| authorships[2].author.display_name | Rajesh Pahwa |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210128618 |
| authorships[2].affiliations[0].raw_affiliation_string | Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center, Kansas City, KS |
| authorships[2].institutions[0].id | https://openalex.org/I4210128618 |
| authorships[2].institutions[0].ror | https://ror.org/036c9yv20 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210128618 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | University of Kansas Medical Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Rajesh Pahwa |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center, Kansas City, KS |
| authorships[3].author.id | https://openalex.org/A5007059433 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-9198-5594 |
| authorships[3].author.display_name | David Gray |
| authorships[3].affiliations[0].raw_affiliation_string | Vigil Neuroscience, Inc, Watertown, MA |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | David Gray |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Vigil Neuroscience, Inc, Watertown, MA |
| authorships[4].author.id | https://openalex.org/A5063175442 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Sridhar Duvvuri |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210165661 |
| authorships[4].affiliations[0].raw_affiliation_string | Cerevel Therapeutics, Boston, MA |
| authorships[4].institutions[0].id | https://openalex.org/I4210165661 |
| authorships[4].institutions[0].ror | https://ror.org/05ed6gd68 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210165661 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Cerevel Therapeutics (United States) |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Sridhar Duvvuri |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Cerevel Therapeutics, Boston, MA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.prdoa.2023.100212 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10085 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994999766349792 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2728 |
| primary_topic.subfield.display_name | Neurology |
| primary_topic.display_name | Parkinson's Disease Mechanisms and Treatments |
| related_works | https://openalex.org/W2416992253, https://openalex.org/W2465771749, https://openalex.org/W2529791985, https://openalex.org/W4250693265, https://openalex.org/W4210409958, https://openalex.org/W2068781960, https://openalex.org/W2010031866, https://openalex.org/W2003790404, https://openalex.org/W2154463282, https://openalex.org/W2027573451 |
| cited_by_count | 33 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 16 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 15 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1016/j.prdoa.2023.100212 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210203201 |
| best_oa_location.source.issn | 2590-1125 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2590-1125 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Clinical Parkinsonism & Related Disorders |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Clinical Parkinsonism & Related Disorders |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.prdoa.2023.100212 |
| primary_location.id | doi:10.1016/j.prdoa.2023.100212 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210203201 |
| primary_location.source.issn | 2590-1125 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2590-1125 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Clinical Parkinsonism & Related Disorders |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Clinical Parkinsonism & Related Disorders |
| primary_location.landing_page_url | https://doi.org/10.1016/j.prdoa.2023.100212 |
| publication_date | 2023-01-01 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2593361577, https://openalex.org/W2904404980, https://openalex.org/W2621950860, https://openalex.org/W3114410799, https://openalex.org/W2464977649, https://openalex.org/W2755433862, https://openalex.org/W2089522371, https://openalex.org/W2741194734, https://openalex.org/W2161814609, https://openalex.org/W2618863395, https://openalex.org/W1964638394, https://openalex.org/W2786241138, https://openalex.org/W1971982338, https://openalex.org/W2516348886, https://openalex.org/W6726304252, https://openalex.org/W3010983304, https://openalex.org/W173375963, https://openalex.org/W3042366596, https://openalex.org/W2586761786, https://openalex.org/W2971102518, https://openalex.org/W2566902429, https://openalex.org/W2168954492, https://openalex.org/W2894147204, https://openalex.org/W2408526765, https://openalex.org/W3021020435, https://openalex.org/W2007696968, https://openalex.org/W2155694557, https://openalex.org/W2172799329, https://openalex.org/W2056061278, https://openalex.org/W2039014242, https://openalex.org/W2160260282, https://openalex.org/W3006235880, https://openalex.org/W3127467109, https://openalex.org/W2046179803, https://openalex.org/W2327641061, https://openalex.org/W1997274212, https://openalex.org/W6689386523, https://openalex.org/W2516561743, https://openalex.org/W6639850709, https://openalex.org/W1972871057, https://openalex.org/W2013195910, https://openalex.org/W2107096821, https://openalex.org/W6607111862, https://openalex.org/W2290883297, https://openalex.org/W2900819074, https://openalex.org/W3002087360, https://openalex.org/W3009754436, https://openalex.org/W2793734433, https://openalex.org/W1966740216, https://openalex.org/W1979214750, https://openalex.org/W2084024459, https://openalex.org/W2054617370, https://openalex.org/W2028466783, https://openalex.org/W2053959292, https://openalex.org/W2028487839, https://openalex.org/W2011033234, https://openalex.org/W2807135302, https://openalex.org/W2888856532, https://openalex.org/W2142558965, https://openalex.org/W2153641048, https://openalex.org/W2904317344, https://openalex.org/W2105035735, https://openalex.org/W1984917376, https://openalex.org/W2006802178, https://openalex.org/W3046447740, https://openalex.org/W2045451128, https://openalex.org/W2169584475, https://openalex.org/W1977508626, https://openalex.org/W2088466254, https://openalex.org/W2895759590, https://openalex.org/W3213060608, https://openalex.org/W2913253889, https://openalex.org/W2940090146, https://openalex.org/W2903447476, https://openalex.org/W2091991835, https://openalex.org/W2108901766, https://openalex.org/W1970571433, https://openalex.org/W2047185717, https://openalex.org/W2138389486, https://openalex.org/W2908907467, https://openalex.org/W2069005897, https://openalex.org/W2085038145, https://openalex.org/W4290975810, https://openalex.org/W2106966901, https://openalex.org/W2560845298, https://openalex.org/W2152394711, https://openalex.org/W1993579512, https://openalex.org/W2898426611, https://openalex.org/W2805951153, https://openalex.org/W1964684914, https://openalex.org/W6692776986, https://openalex.org/W2151474354, https://openalex.org/W3006857739, https://openalex.org/W3170641464, https://openalex.org/W1612007229, https://openalex.org/W4226327181, https://openalex.org/W1899398703, https://openalex.org/W2906377653, https://openalex.org/W4298379583, https://openalex.org/W2901519529, https://openalex.org/W2263405074, https://openalex.org/W2228562475 |
| referenced_works_count | 102 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5063175442 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I4210165661 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.98053086 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |